Office of Management and Budget
Executive Office of the President
  Site Search     
 
About OMB  
- Organization Chart
- Contact OMB
 
President's Budget
- Budget Documents
- Supplementals, Budget Amendments, and Releases
Federal Management
- President's Management Agenda
- Office of Federal Financial
Management
-- Agency Audits
- Office of Federal Procurement
Policy
  -- CAS Board
-- FAIR Act Inventory
Office of Information and Regulatory Affairs
- OIRA Administrator
- Regulatory Matters
- Paperwork Requirements
- Statistical Programs & Standards
- Information Policy, IT & E-Gov
Communications & Media
- News Releases
- Speeches
Legislative Information
- Statements of Administration Policy (SAPs)
- Testimony
- Reports to Congress
Information for Agencies
- Circulars
- Memoranda
- Bulletins
- Pivacy Guidance
- Grants Management
- Reports
Site Map
First Gov  
eGov
|

Meeting Record Regarding: Use of Ozone Depleting Substances Removal of Essential Use Designation

Date: 5/11/2004

Name Affiliation Client (if applicable)
Fumie Yokota OMB  
Matthew Vaeth OMB/Health Division  
Loren Monroe Barbour Griffith & Rogers, Inc. GlaxoSmithKline
Sally Walsh GlaxoSmithKline  
Emily Bishko National Economic Research Associates, Inc.  
Richard Rozek National Economic Research Associates, Inc.  
Dominic Mancini OMB  
Brenda Aguilar OMB  
John Morrall OMB  
Don Arbuckle OMB  
Robert Meyer FDA (by phone)  
Wayne Mitchell FDA (by phone)